back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-01-06 14:18 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+15,000 vol |
15,000 | |
| Filed 2021-01-06 14:17 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-06 12:59 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
135,000 | |
| Filed 2020-08-21 22:27 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,000
+20,000 vol $0.60 each |
125,000 | |
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
105,000 | |
| Filed 2018-04-12 Tx date 2018-04-06 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+20,000 vol $0.48 each |
117,132 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
80,000 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
97,132 | |
| Filed 2018-03-16 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-02-07 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+194,264 vol |
194,264 | |
| Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+194,264 vol |
388,528 | |
| Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
||
| Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
||
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-102,959.92
-194,264 vol $0.53 each |
194,264 | |
| Filed 2018-03-16 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
||
| Filed 2018-03-16 Tx date 2018-03-09 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$51,479
+97,132 vol $0.53 each |
||
| Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
40,000 | |
| Filed 2017-06-28 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-31 Tx date 2017-05-24 |
$CTX
Crescita Therapeutics Inc. |
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,150 |